BLAVATNIK CENTER for Drug Discovery

The BLAVATNIK CENTER for Drug Discovery (BCDD) is a leading research institution committed to advancing early-stage drug discovery and translating academic innovations into promising new drug candidates. Located at Tel Aviv University, Ramat Aviv in the Cohen-Porter Family United Kingdom Building (Britannia), 1st floor, Tel Aviv, 69978, IL, the BCDD offers a state-of-the-art R&D environment and academic platform for researchers.

BLAVATNIK CENTER for Drug Discovery focuses on providing the academic environment, expertise, and infrastructure necessary to develop disease models and biological assays for effective drug screening. The BCDD supports advancing early-stage drug candidates through optimization and target validation pipelines, utilizing cutting-edge research methodologies and automated infrastructure.

With a commitment to excellence, the BLAVATNIK CENTER for Drug Discovery is dedicated to reaching industrial requirements through academic R&D, contributing significantly to treatments for rare diseases and personalized medicine. BLAVATNIK CENTER for Drug Discovery management is currently working to provide a detailed overview of our latest advancements. We invite the manager of BLAVATNIK CENTER for Drug Discovery to create a customized and exclusive company showcase and product listing on our platform.